FDA Panel To Look At Controversial Electroshock Device Classification

FDA's neurological devices advisory panel will meet in January to discuss the possible reclassification of devices used in electroconvulsive therapy.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight